Macular Infarction After Intravitreal Amikacin: Authors' Reply
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Kwok A, Hui M, Pang C, Chan R, Cheung S, Yip C
. An in vitro study of ceftazidime and vancomycin concentrations in various fluid media: implications for use in treating endophthalmitis. Invest Ophthalmol Vis Sci. 2002; 43(4):1182-8.
View
2.
Galloway G, Ramsay A, Jordan K, Vivian A
. Macular infarction after intravitreal amikacin: mounting evidence against amikacin. Br J Ophthalmol. 2002; 86(3):359-60.
PMC: 1771055.
DOI: 10.1136/bjo.86.3.359.
View
3.
Mochizuki K, Yamashita Y, Torisaki M, Komatsu M, Tanahashi T, Kawasaki K
. Intraocular kinetics of ceftazidime (Modacin). Ophthalmic Res. 1992; 24(3):150-4.
DOI: 10.1159/000267161.
View
4.
Doft B, Barza M
. Macular infarction after intravitreal amikacin. Br J Ophthalmol. 2004; 88(6):850.
PMC: 1772176.
DOI: 10.1136/bjo.2003.038885.
View
5.
Simon C, Littschwager G
. In vitro activity of ceftazidime in combination with other antibiotics. Infection. 1985; 13(4):184-9.
DOI: 10.1007/BF01642810.
View